Fasenra pen 30 MG/mlml

Ended Awarded

Contract number
SPE2DR26FRRK9
Awardee
Awarding agency
Obligated
$7,481

Award facts

Contract value 100% obligated
$7,481.25 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on January 7, 2026, with a ceiling value of $7,481.25 for Fasenra (reslizumab) 30 mg/mL, a biologic medication for severe eosinophilic asthma.

DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract (SPE2DX) with a ceiling through December 31, 2036. Place of performance is Park Ridge, IL, with delivery to Department of Defense military healthcare facilities worldwide. The order is firm fixed price with an ultimate completion date of January 8, 2026.

Quick answers

Who was awarded contract SPE2DR26FRRK9?

SPE2DR26FRRK9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.

How much is contract SPE2DR26FRRK9 worth?

The government has obligated $7,481 on SPE2DR26FRRK9.

Is contract SPE2DR26FRRK9 an order under another contract?

Yes. SPE2DR26FRRK9 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.

Was contract SPE2DR26FRRK9 competed?

The extent of competition for SPE2DR26FRRK9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award